Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance? by Paul L Boyer, Stefan G Sarafianos, Patrick K Clark, Eddy Arnold, Stephen H Hughes

Get full text

Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining. by Lulu Yu, Vladimir Majerciak, Xiang-Yang Xue, Aayushi Uberoi, Aayushi Uberoi, Alexei Lobanov, Xiongfong Chen, Maggie Cam, Stephen H Hughes, Paul F Lambert, Zhi-Ming Zheng

Get full text

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir. by John K Bui, Michele D Sobolewski, Brandon F Keele, Jonathan Spindler, Andrew Musick, Ann Wiegand, Brian T Luke, Wei Shao, Stephen H Hughes, John M Coffin, Mary F Kearney, John W Mellors

Get full text

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy. by John M Coffin, Michael J Bale, Daria Wells, Shuang Guo, Brian Luke, Jennifer M Zerbato, Michele D Sobolewski, Twan Sia, Wei Shao, Xiaolin Wu, Frank Maldarelli, Mary F Kearney, John W Mellors, Stephen H Hughes

Get full text